Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.24.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Components of Income Tax Expense (Benefit)

Components of income tax expense (benefit) were as follows (in thousands):

Year Ended December 31, 

    

2023

    

2022

    

2021

Current

$

(140)

$

8,476

$

132

Deferred

 

18,485

 

45,184

 

(8,189)

Total income tax expense (benefit)

$

18,345

$

53,660

$

(8,057)

Schedule of Effective Income Tax Rate Reconciliation

The Company’s income tax expense (benefit) for 2023, 2022 and 2021 resulted in effective tax rates of 54.0%, 18.8% and (16.3)%, respectively. The reconciliation of income taxes computed at the U.S. federal statutory tax rate of 21% to these effective tax rates is as follows (in thousands):

Year Ended December 31, 

    

2023

    

2022

    

2021

Income tax expense (benefit) at the federal statutory rate

$

7,128

$

59,810

$

(10,402)

Compensation adjustments

 

1,752

 

599

 

559

State income taxes

 

1,143

 

2,418

 

(330)

Valuation allowance

 

8,125

 

(9,117)

 

1,863

Other

 

197

 

(50)

 

253

Total income tax expense (benefit)

$

18,345

$

53,660

$

(8,057)

Schedule of Deferred Tax Assets and Liabilities

December 31, 

    

2023

    

2022

Deferred tax assets:

 

  

 

  

Derivatives

$

8,532

$

25,969

Asset retirement obligations

 

109,111

 

103,910

Contingent asset retirement obligations

3,952

4,540

Right of use liability

2,895

2,964

Federal net operating losses

 

6,211

 

281

State net operating losses

 

5,941

 

5,691

Interest expense limitation carryover

 

17,501

 

9,620

Share-based compensation

 

2,262

 

1,546

Other

 

4,266

 

5,513

Total deferred tax asset

160,671

160,034

Valuation allowance

 

(23,202)

 

(15,311)

Total deferred tax asset after valuation allowance

 

137,469

 

144,723

Deferred tax liabilities:

  

  

Property and equipment

$

92,707

$

80,616

Investment in non-consolidated entity

 

2,993

 

3,951

Other

 

3,046

 

2,948

Total deferred tax liabilities

 

98,746

 

87,515

Net deferred tax asset

$

38,723

$

57,208

Schedule of Changes to the Company's valuation allowance

Changes to the Company’s valuation allowance are as follows (in thousands):

Year Ended December 31, 

    

2023

    

2022

    

2021

Balance at beginning of period

$

(15,311)

$

(24,359)

$

(22,361)

Additions to valuation allowance

(7,891)

(1,998)

Reductions to valuation allowance

 

 

9,048

 

Balance at end of period

$

(23,202)

$

(15,311)

$

(24,359)

Summary of Operating Loss Carryforwards

The table below presents the details of the Company’s net operating loss and interest expense limitation carryover as of December 31, 2023 (in thousands):

    

Amount

    

Expiration
Year

Federal net operating loss

$

29,578

 

N/A

State net operating loss

 

100,903

 

2026-2042

Interest expense limitation carryover

 

79,914

 

N/A